QUOTE AND NEWS
Forbes  Jan 30  Comment 
Two ancient skeletons found in La Jolla, California, the subject of a decade-long legal battle, will be returned to Native Americans for repatriation.
New York Times  Jan 29  Comment 
For years the remains have been out of reach, the subject of a legal struggle that pitted 3 scientists against their own administration and the Kumeyaay.
GenEng News  Dec 10  Comment 
Scientists at the La Jolla Institute for Allergy and Immunology say they have demonstrated that TET (ten-eleven translocation) proteins collectively constitute a major class of tumor suppressors and are required to maintain genome stability. Their...
Benzinga  Nov 30  Comment 
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced the...
Benzinga  Sep 11  Comment 
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the "Company" or "La Jolla"), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that...
Benzinga  Sep 8  Comment 
La Jolla Pharmaceutical Company (NASDAQ: LJPC) shares touched a new 52-week high of $36.83. La Jolla Pharmaceutical shares have jumped 246.65 percent over the past 52 weeks, while the S&P 500 index has declined 4.01 percent in the same period. ...
Benzinga  Aug 10  Comment 
In a report published Monday, Chardan Capital Markets analyst Gbola Amusa maintained a Buy rating on La Jolla Pharmaceutical Company (NASDAQ: LJPC), with a price target of $60. Analyst Gbola Amusa commented, “Post Q2 results, we update our...
GenEng News  Jul 31  Comment 
Scientists at the La Jolla Institute for Allergy and Immunology say they have identified a pair of master regulators that control the fate of follicular helper T (TFH) cells, which are essential for inducing a strong and lasting antibody response...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki